Zhao Hong, Li Junsheng, Li Li, Wang Hang, Guo Jianming, Miao Yi
Department of Urology, Shanghai Xu-Hui Central Hospital, No 966, Huaihai Road, Shanghai 200032, China.
Department of Urology, Zhongshan Hospital, Fudan University, No 180, Fenglin Road, Shanghai 200032, China.
Appl Bionics Biomech. 2022 Jun 6;2022:6775277. doi: 10.1155/2022/6775277. eCollection 2022.
This study was designed to evaluate the aspects that affect transfusion following percutaneous nephrolithotomy (PCNL). . From 2016 to 2019, 665 patients underwent PCNL for the removal of renal calculi at our center (Department of Urology, Shanghai Xu-hui Central Hospital). Complications, including hemorrhages, have been reported. Twenty-three patients (3.5%) have received a blood transfusion, and 12 (1.9%) patients were treated with hyper-selective embolization. We focused on the influencing factors related to postoperative blood transfusion. The factors analyzed were age, sex, hypertension, diabetes, serum creatinine level, preoperative hemoglobin, and the use of anticoagulants or antiplatelet medications; renal and stone factors (i.e., previous surgery, abnormal anatomy, stone side, stone burden, and stone type); and surgical features (i.e., access number, the calyx of puncture, and stone-free rate). These data were analyzed for the presence of bleeding.
Among individual factors, preoperative hemoglobin level ( < 0.001) and urinary infections ( < 0.001) were significantly correlated with blood transfusion. Among renal and stone factors, only a history of open surgery was significantly correlated with blood transfusion ( < 0.05). Stone type or stone burden did not correlate with transfusion. Furthermore, no statistically significant correlation was found between surgical features and bleeding, and a lower stone-free rate was reported for the transfusion group.
The obtained results demonstrated that PCNL is a safer surgical procedure in a high-volume center; however, anemic conditions, infections, and history of open surgery will significantly increase the transfusion rate following PCNL.
本研究旨在评估经皮肾镜取石术(PCNL)后影响输血的相关因素。2016年至2019年,665例患者在我院中心(上海徐汇区中心医院泌尿外科)接受PCNL治疗肾结石。已报告包括出血在内的并发症。23例患者(3.5%)接受了输血,12例患者(1.9%)接受了超选择性栓塞治疗。我们重点关注与术后输血相关的影响因素。分析的因素包括年龄、性别、高血压、糖尿病、血清肌酐水平、术前血红蛋白以及抗凝剂或抗血小板药物的使用;肾脏和结石因素(即既往手术史、解剖结构异常、结石侧别、结石负荷和结石类型);以及手术特征(即穿刺通道数量、穿刺肾盏和结石清除率)。对这些数据进行出血情况分析。
在个体因素中,术前血红蛋白水平(<0.001)和泌尿系统感染(<0.001)与输血显著相关。在肾脏和结石因素中,只有开放手术史与输血显著相关(<0.05)。结石类型或结石负荷与输血无关。此外,手术特征与出血之间未发现统计学上的显著相关性,且输血组的结石清除率较低。
所得结果表明,在大容量中心,PCNL是一种更安全的手术方法;然而,贫血状况、感染和开放手术史将显著增加PCNL后的输血率。